Joseph R. Bertino

29.2k total citations · 5 hit papers
471 papers, 23.2k citations indexed

About

Joseph R. Bertino is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Joseph R. Bertino has authored 471 papers receiving a total of 23.2k indexed citations (citations by other indexed papers that have themselves been cited), including 236 papers in Molecular Biology, 163 papers in Oncology and 71 papers in Rheumatology. Recurrent topics in Joseph R. Bertino's work include Biochemical and Molecular Research (79 papers), Acute Lymphoblastic Leukemia research (69 papers) and Folate and B Vitamins Research (62 papers). Joseph R. Bertino is often cited by papers focused on Biochemical and Molecular Research (79 papers), Acute Lymphoblastic Leukemia research (69 papers) and Folate and B Vitamins Research (62 papers). Joseph R. Bertino collaborates with scholars based in United States, Italy and Germany. Joseph R. Bertino's co-authors include Debabrata Banerjee, Carlos Cordon‐Cardo, James P. O’Brien, M R Melamed, Prasun Mishra, Richard Görlick, Rodney E. Kellems, F W Alt, John J. McGuire and June L. Biedler and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Joseph R. Bertino

462 papers receiving 21.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic effect of weight loss prior tochemotherapy in cancer patients

1980 1.8k citations Joseph R. Bertino, Roland T. Skeel et al. profile →
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

1989 1.4k citations Joseph R. Bertino et al. profile →
Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

1990 885 citations Joseph R. Bertino et al. profile →
Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells.

1978 816 citations Joseph R. Bertino et al. profile →
Molecular Actions and Targets for Cancer Chemotherapeutic Agents

1981 298 citations Joseph R. Bertino et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph R. Bertino United States	75	10.2k	8.6k	2.9k	2.5k	2.4k	471	23.2k
Herbert M. Pinedo Netherlands	91	12.1k 1.2×	15.8k 1.8×	1.1k 0.4×	3.5k 1.4×	3.9k 1.6×	571	29.8k
Ulf‐Håkan Stenman Finland	70	5.5k 0.5×	4.1k 0.5×	2.5k 0.9×	2.4k 1.0×	4.7k 2.0×	608	20.1k
Klaus‐Michael Debatin Germany	85	20.6k 2.0×	6.5k 0.8×	1.4k 0.5×	5.1k 2.0×	1.1k 0.4×	521	33.1k
Scott H. Kaufmann United States	95	25.8k 2.5×	11.9k 1.4×	1.2k 0.4×	3.7k 1.5×	1.8k 0.8×	406	36.2k
James F. Holland United States	59	4.3k 0.4×	5.6k 0.7×	1.6k 0.6×	2.1k 0.8×	2.1k 0.9×	400	15.6k
Peter C. Heinrich Germany	75	9.4k 0.9×	11.9k 1.4×	550 0.2×	3.1k 1.2×	1.4k 0.6×	368	27.7k
Peter H. Wiernik United States	69	5.2k 0.5×	7.1k 0.8×	3.4k 1.2×	669 0.3×	2.6k 1.1×	511	19.7k
Takashi Tsuruo Japan	89	16.6k 1.6×	12.4k 1.4×	715 0.2×	2.8k 1.1×	1.2k 0.5×	446	27.7k
Tatsuhiko Kodama Japan	89	20.1k 2.0×	6.7k 0.8×	590 0.2×	4.9k 2.0×	1.6k 0.7×	426	36.3k
Kapil N. Bhalla United States	87	17.3k 1.7×	5.9k 0.7×	1.2k 0.4×	2.2k 0.9×	1.1k 0.5×	378	26.0k

Countries citing papers authored by Joseph R. Bertino

Since Specialization

Citations

This map shows the geographic impact of Joseph R. Bertino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph R. Bertino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph R. Bertino more than expected).

Fields of papers citing papers by Joseph R. Bertino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph R. Bertino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph R. Bertino. The network helps show where Joseph R. Bertino may publish in the future.

Co-authorship network of co-authors of Joseph R. Bertino

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph R. Bertino. A scholar is included among the top collaborators of Joseph R. Bertino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph R. Bertino. Joseph R. Bertino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morgan, Katherine M., Bruce S. Fischer, Francis Y. Lee, et al.. (2017). Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma. Molecular Cancer Therapeutics. 16(12). 2759–2769. 51 indexed citations

Dolfi, Sonia, Leo Li‐Ying Chan, Jean Qiu, et al.. (2013). The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer & Metabolism. 1(1). 20–20. 147 indexed citations

Bertino, Joseph R., Martin Lubin, Nadine Johnson-Farley, et al.. (2012). Lack of Expression of MTAP in Uncommon T-Cell Lymphomas. Clinical Lymphoma Myeloma & Leukemia. 12(5). 306–309. 6 indexed citations

Moroz, Maxim A., Shangde Cai, Jayasree S. Nair, et al.. (2011). Imaging Colon Cancer Response Following Treatment with AZD1152: A Preclinical Analysis of [18F]Fluoro-2-deoxyglucose and 3′-deoxy-3′-[18F]Fluorothymidine Imaging. Clinical Cancer Research. 17(5). 1099–1110. 28 indexed citations

Humeniuk, Rita, Lata G. Menon, Prasun Mishra, et al.. (2009). Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance. Molecular Cancer Therapeutics. 8(5). 1037–1044. 43 indexed citations

Humeniuk, Rita, Prasun Mishra, Joseph R. Bertino, & Debabrata Banerjee. (2009). Epigenetic reversal of acquired resistance to 5-fluorouracil treatment. Molecular Cancer Therapeutics. 8(5). 1045–1054. 25 indexed citations

Budak-Alpdoǧan, Tülin, et al.. (2009). Retinoblastoma Tumor Suppressor Gene Expression Determines the Response to Sequential Flavopiridol and Doxorubicin Treatment in Small-Cell Lung Carcinoma. Clinical Cancer Research. 15(4). 1232–1240. 7 indexed citations

Saydam, Güray, et al.. (2005). mTOR inhibition leads to increased sensitivity to methotrexate. Cancer Research. 65. 777–778. 3 indexed citations

Mayer‐Kuckuk, Philipp, T. Gade, Ian M. Buchanan, et al.. (2005). High-Resolution Imaging of Bone Precursor Cells Within the Intact Bone Marrow Cavity of Living Mice. Molecular Therapy. 12(1). 33–41. 6 indexed citations

10.

Portlock, C., Jing Qin, Nancy Roistacher, et al.. (2004). The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide. Annals of Oncology. 15(10). 1495–1503. 13 indexed citations

11.

Fan, Jianguo & Joseph R. Bertino. (1999). Modulation of Cisplatinum Cytotoxicity by p53: Effect of p53-Mediated Apoptosis and DNA Repair. Molecular Pharmacology. 56(5). 966–972. 1 indexed citations

12.

Rosowsky, A., Ronald A. Forsch, Sherry F. Queener, & Joseph R. Bertino. (1997). Synthesis of 2,4-Diaminopteridines with Bulky Lipophilic Groups at the 6-Position as Inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mammalian Dihydrofolate Reductase. Pteridines. 8(3). 173–187. 6 indexed citations

13.

Fan, Jian‐Gao, Zbigniew Zieliński, Geoffrey M. Wahl, et al.. (1994). Absence of retinoblastoma protein mediates intrinsic resistance to antimetabolites in human sarcoma cell lines. 35. 418. 2 indexed citations

14.

Volkenandt, Matthias, Olaf Koch, Renato Fanin, et al.. (1992). Sequence analysis of polymerase chain reaction amplified t(14;18) chromosomal breakpoints in formalin fixed, paraffin wax embedded follicular lymphoma.. Journal of Clinical Pathology. 45(3). 210–212. 5 indexed citations

15.

Bertino, Joseph R. & Antonella Romanini. (1990). Modulation of Fluoropyrimidines by Pretreatment with Antifolates or Folinic Acid (Leucovorin). Cancer Investigation. 8(2). 259–260. 1 indexed citations

16.

Lele, P. P., et al.. (1982). Clinical evaluation of local hyperthermia by focused ultrasound (abstract). Europe PMC (PubMed Central). 5. 248–248. 2 indexed citations

17.

Bertino, Joseph R., et al.. (1978). Immobilized carboxypeptidase G1 in methotrexate removal.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(7). 1936–41. 6 indexed citations

18.

Skeel, Roland T., et al.. (1974). Clinical and pharmacological studies of the folate antagonist, triazinate (Baker's antifol, TZT). Proceedings of the American Association for Cancer Research. 15. 3 indexed citations

19.

Chabner, Bruce A., D G Johns, & Joseph R. Bertino. (1972). Enzymatic Cleavage of Methotrexate provides a Method for Prevention of Drug Toxicity. Nature. 239(5372). 395–397. 50 indexed citations

20.

Bertino, Joseph R.. (1971). Folate antagonists as chemotherapeutic agents. New York Academy of Sciences eBooks. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact